Literature DB >> 3970859

The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classification.

S J May, S A Smith, A Jacobs, A Williams, R Bailey-Wood.   

Abstract

A detailed study of 43 newly diagnosed cases of myelodysplastic syndrome (MDS) shows that many of the morphological features of blood and bone marrow are common to the different FAB groups. In addition, there is no clear distinction between the groups with regard to CFU-E, BFU-E or CFU-GM colony growth in vitro or ferrokinetic assessment of erythropoiesis in vivo. The interrelationships between all the parameters we have studied have been examined and there is little correlation between erythroid colony formation in vitro, the percentage erythroblasts in the bone marrow, erythroid output measured by ferrokinetics and the peripheral blood reticulocyte count, all of which appear to measure different aspects of erythropoiesis. Reduced erythroid colony growth and a high degree of ineffective erythropoiesis in vivo are common in all groups and appear to be an early manifestation of abnormal function. Decreasing marrow iron turnover is more closely related to increasing numbers of marrow blast cells than any other index of erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970859     DOI: 10.1111/j.1365-2141.1985.tb02996.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Biological and clinical significance of clonogenic assays in patients with myelodysplastic syndromes.

Authors:  D Marisavljević; Z Rolović; D Sefer; N Basara; D Ilić; D Bosković; M Colović
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

2.  Familial myelodysplasia.

Authors:  G S Lucas; R R West; A Jacobs
Journal:  BMJ       Date:  1989-08-26

3.  Refractory myelodysplastic anaemias with hypocellular bone marrow.

Authors:  Y Yoshida; S Oguma; H Uchino; T Maekawa
Journal:  J Clin Pathol       Date:  1988-07       Impact factor: 3.411

Review 4.  Myelodysplastic syndromes.

Authors:  D C Doll; A F List
Journal:  West J Med       Date:  1989-08

5.  Comparative ferrokinetic study with initial and extended iron clearance models.

Authors:  J E Howarth; H M Waters; K Hyde; D Shanks; C G Geary
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

6.  Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features.

Authors:  G E Verhoef; C De Wolf-Peeters; A Ferrant; S Deprez; P Meeus; M Stul; P Zacheé; J J Cassiman; H Van den Berghe; M A Boogaerts
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

7.  Platelet dysfunction as the presenting feature of atypical myelodysplastic syndrome with monosomy 7, normal blood counts and no bleeding tendency.

Authors:  D Marisavljević; P Antunović; P Miljić; M Pantić
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

8.  Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition.

Authors:  Craig Dorrell; Katsuto Takenaka; Mark D Minden; Robert G Hawley; John E Dick
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 9.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

10.  Mutant N-RAS induces erythroid lineage dysplasia in human CD34+ cells.

Authors:  R L Darley; T G Hoy; P Baines; R A Padua; A K Burnett
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.